Case Study: Negligence Claim Based on Design Defect Seasoned Experts, Swift Action Led to a Defense Verdict for Medmarc Insured EXECUTIVE SUMMARY The owner of a motorized scooter carrier rack suffered...
Case Study: Medmarc Defense Team Prevails in a Case Against a Light Therapy Device Manufacturer EXECUTIVE SUMMARY The plaintiff, in this case, suffered permanent scarring from burns left by an intense...
CMO Liability: Protect Your Business From Additional Risk Part three of a three-part series on the Contract Development and Manufacturing industry and potential products liability and manufacturers...
CMO FDA Regulation: Are CMOs Regulated by the FDA? Part two of a three-part series on the Contract Development and Manufacturing industry and potential products liability and manufacturers E&O risks.
The CMO Landscape: Diversifying to Meet an Evolving Industry Part one of a three-part series on the Contract Development and Manufacturing industry and potential products liability and manufacturers...
Created by the medical technology and life sciences industry in 1979, Medmarc has grown from a small insurance program to insuring the life sciences industry. This series takes a look at the last four...
The United States is widely regarded as the most litigious country in the world―and for good reason.
There are a couple of other elements complicating the products liability litigation landscape for life sciences companies that deserve consideration.
Being the recipient of a lawsuit is unsettling and disruptive to any company. Not only can it be expensive to defend against, but the process can be complex.
The tripartite relationship describes the dynamic between an insurer, an insured, and a defense attorney hired by the insurer to defend the insured.
Any number and variety of crises can threaten a life sciences company and ultimately interrupt its operations, its bottom line, and damage its brand reputation.
Imagine you learn of a serious adverse event that involves your product.
This second installment of our Litigation 360 series on Crisis Management addresses actions that a life sciences company can take immediately following notice of an adverse event.
Large or small, every life science or medical technology company will eventually have to deal with a products liability claim or event.
How will your life sciences company manage the expenses associated with this flood of litigation?
